HeimBNTX • NASDAQ
add
BioNTech SE ADR
113,52 $
Eftir lokun(0,00%)0,00
113,52 $
Lokað: 15. ágú., 17:21:36 GMT-4 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
112,70 $
Dagbil
111,72 $ - 114,10 $
Árabil
81,20 $ - 131,49 $
Markaðsvirði
27,24 ma. USD
Meðalmagn
664,62 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (EUR) | jún. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 260,80 m. | 102,64% |
Rekstrarkostnaður | 621,10 m. | -39,74% |
Nettótekjur | -386,60 m. | 52,14% |
Hagnaðarhlutfall | -148,24 | 76,38% |
Hagnaður á hvern hlut | -1,60 | 52,38% |
EBITDA | -385,70 m. | 57,70% |
Virkt skatthlutfall | 4,00% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (EUR) | jún. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 14,04 ma. | -18,84% |
Heildareignir | 21,64 ma. | -2,70% |
Heildarskuldir | 3,13 ma. | -1,05% |
Eigið fé alls | 18,51 ma. | — |
Útistandandi hlutabréf | 240,40 m. | — |
Eiginfjárgengi | 1,46 | — |
Arðsemi eigna | -5,10% | — |
Ávöxtun eigin fjár | -5,75% | — |
Peningaflæði
Breyting á handbæru fé
| (EUR) | jún. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | -386,60 m. | 52,14% |
Handbært fé frá rekstri | 146,50 m. | -91,00% |
Reiðufé frá fjárfestingum | -64,40 m. | 73,32% |
Reiðufé frá fjármögnun | -13,30 m. | 41,92% |
Breyting á handbæru fé | 84,60 m. | -93,96% |
Frjálst peningaflæði | -292,96 m. | -116,69% |
Um
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
Framkvæmdastjóri
Stofnsett
2008
Vefsvæði
Starfsfólk
6.772
